Open access · CC-BY
via OpenAlex
A narrative review of hydrogen therapy for COPD: aging-related insights
Ya-Ting Chuang, Chun Tseng, Tao-An Chen
Open Medicine · 2026
Cellular senescence
Chronic inflammation
Exercise
Human
Randomized controlled trial
Preclinical / animal
Review
Abstract
Abstract Objectives Molecular hydrogen (H 2 ) exhibits selective antioxidant, anti-inflammatory, and anti-senescence(definition) properties that may provide therapeutic benefits for chronic obstructive pulmonary disease (COPD), particularly in aging populations where oxidative stress and chronic inflammation are prominent. Given the increasing burden of aging-related COPD and the emerging biological effects of molecular hydrogen, we hypothesized that H 2 therapy may exert beneficial effects by modulating oxidative stress, inflammation, and aging pathways. Methods Following Ferrari’s narrative review framework, PubMed and Ovid MEDLINE were searched through October 2025 for clinical and preclinical studies examining H 2 interventions in COPD, chronic bronchitis, or emphysema, with emphasis on elderly populations or aging-related models. Results Three studies met the inclusion criteria: one animal experiment, one prospective clinical study, and one randomized controlled trial. H 2 administration, via inhalation or H 2 -rich water, significantly reduced inflammatory cytokines (IL-1β, IL-6, TNF-α), oxidative markers (8-OHdG), and senescence indicators (p16, p21, β-gal). Clinical findings demonstrated improved arterial blood gases, acid–base balance, and exercise tolerance in elderly COPD patients. Conclusions H 2 therapy shows consistent antioxidative, anti-inflammatory, and anti-senescence effects across preclinical and clinical settings, suggesting potential as an adjunctive treatment for COPD in aging populations. Further large-scale, long-term trials are warranted to confirm efficacy, optimize dosage, and clarify mechanistic pathways.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1515/med-2026-1438
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Chuang, Y., Tseng, C., & Chen, T. (2026). A narrative review of hydrogen therapy for COPD: aging-related insights. <em>Open Medicine</em>. https://doi.org/10.1515/med-2026-1438
Vancouver
Chuang Y, Tseng C, Chen T. A narrative review of hydrogen therapy for COPD: aging-related insights. Open Medicine. 2026. doi:10.1515/med-2026-1438.
BibTeX
@article{yating2026Anarra,
title = {A narrative review of hydrogen therapy for COPD: aging-related insights},
author = {Ya-Ting Chuang and Chun Tseng and Tao-An Chen},
journal = {Open Medicine},
year = {2026},
doi = {10.1515/med-2026-1438},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Pharmaceutical Design 2011
Open access · OA
Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications
Nutrients 2026
Citation only
Inflammaging and Sarcopenia as Interconnected Hallmarks of Aging: Integrative Roles of Bioactive Compounds and Lifestyle Interventions.
Nutrients 2026
Open access · CC-BY
Inflammaging and Sarcopenia as Interconnected Hallmarks of Aging: Integrative Roles of Bioactive Compounds and Lifestyle Interventions
Pharmaceuticals (Basel, Switzerland) 2026
Open access · OA
Lithium as a Potential Senostatic Agent in Central Nervous System Aging and Bipolar Disorder.
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Nutrients 2026
Open access · CC-BY